Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Founder operating in the Medical Device space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
_______
Brent Clements
Founder & CEO of Addiction Campuses of America
Brent is an accomplished entrepreneur, executive, and healthcare visionary. With over 20 years experience in senior leadership roles for multiple organizations in the healthcare and technology industries, Brent has a clear plan for what is required to build a successful company. Brent’s passion for helping those families in need inspired the founding of Addiction Campuses. Throughout his professional career Brent has developed expertise in creating strategy for the future, maximizing organizational efficiency, and building relationships with care givers, employees and community partners who drive change. Ultimately Brent believes “If they change the core belief system, the mindset changes and good behavior follows”. That is what Addiction Campuses is all about. He was recognized as one of Nashville Business Journal’s 40 Under 40 in 2011 and Healthcare Heroes nominee in 2010. Brent is married to his wife, Vicki, and they have two sons.
Follow Brent Clements:
About Addiction Campuses of America: Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.
Brad Packer
Founder and CEO of Vitality Medical
Brad is the brains behind it all. Brad started Vitality Medical in 2000 shortly after completing his graduate degree from Medical College of Virginia. While employed as a registered nurse Brad recognized the need for online medical supplies and seized the opportunity to start Vitality Medical. Working weekend nights as a nurse and weekdays as entrepreneur Brad and his team of dedicated co-workers have created one of the foremost leading companies in the online medical supply market.
Follow Brad Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Stefano Migliorisi
Founder & CEO of swyMed Incorporated
Follow Stefano Migliorisi:
About swyMed Incorporated: swyMed’s solutions power truly mobile, real-time video telemedicine encounters at the lowest bandwidths.
Gregory Winter
Scientific Founders of Bicycle Therapeutics
Professor Sir Gregory Winter is a member of the Medical Research Council Laboratory of Molecular Biology (LMB) in Cambridge and most of his scientific career was based there. He was Head of Division of Protein and Nucleic Acid Chemistry, succeeding Cesar Milstein and has served as both Deputy and Acting Director of the LMB. He is a Fellow of the Royal Society, was knighted in 2004 for services to science and in 2012 was appointed by the Queen as Master of Trinity College, Cambridge. Sir Gregory is a graduate of University of Cambridge (1973), specialising in chemistry and biochemistry; for his PhD (1976) and postdoctoral work (1977-1981) he specialised in protein and nucleic acid sequencing respectively and with colleagues determined the genome sequence of influenza virus. From 1982 he pioneered the science of protein engineering, focusing first on enzymes (with A. Fersht) and then antibodies. He invented techniques to humanise rodent antibodies for use as therapeutics (1986–), working with H. Waldmann in the development of alemtuzumab/Campath-1H. Later, in competition with R. Lerner, he developed methods to make fully human antibodies (1989–) against human self-antigens using antibody libraries. His inventions are used in most of the antibody products on the market, including the humanised antibodies alemtuzumab/Campath-1H, trastuzumab/Herceptin, bevacizumab/Avastin, palivizumab/Synagis and the first human antibody (adalimumab/Humira) to be approved by the US FDA. Sir Gregory has acted as an entrepreneur to translate his scientific inventions to medicines. He was a founder of Cambridge Antibody Technology (CAT,1989) and Domantis (2000); these companies pioneered the use of antibody libraries to make fully human antibody therapeutics. CAT was floated on the London Stock Exchange in 1997 and was responsible for the co-development of the therapeutic antibodies adalimumab/Humira and belimumab/Benlysta. CAT was acquired by AstraZeneca in 2006. Domantis developed a range of product leads based on single antibody domains and was acquired by GSK in 2006 in a private sale. Sir Gregory has won several international scientific prizes, including the Prix Louis Jeantet de Medecine (Switzerland) in 1989; the King Faisal International Prize for Medicine (Molecular Immunology, Saudi Arabia) in 1995; the Biochemical Analysis Prize of the German Society for Clinical Chemistry in 1995; the Cancer Research Institute William B. Coley Award (US) in 1999; and the Royal Medal of the Royal Society in 2011. For his work with industry, he received the National Biotechnology Ventures Award (US) in 2004 and the BioIndustry Association Award (UK) in 2008. In March 2013 he was awarded the Gairdner Prize for the engineering of humanised monoclonal antibodies and their widespread use in medical therapy, particularly for treatment of cancer and immune disorders.
Follow Gregory Winter:
About Ahren Innovation Capital, Bicycle Therapeutics, MRC Laboratory of Molecular Biology, Trinity College, Dublin: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Christian Heinis
Scientific Founders of Bicycle Therapeutics
Christian Heinis is Scientific Founders at Bicycle Therapeutics.
Follow Christian Heinis:
About Bicycle Therapeutics: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Andrew Ninh
Co-Founder and CSO of Docbot
Follow Andrew Ninh:
About Docbot: Docbot is an AI technology company that offers AI-assisted image analysis solutions to revolutionize gastrointestinal care.
William Karnes
Co-Founder and Chief Medical Officer of Docbot
Follow William Karnes:
About Docbot, UC Irvine Health: Docbot is an AI technology company that offers AI-assisted image analysis solutions to revolutionize gastrointestinal care.
Jennifer Jacobs
Co-Founder COO of PerceptiMed
Follow Jennifer Jacobs:
About PerceptiMed: PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Jennifer Jacob
Co-Founder of PerceptiMed
With a successful background in accounting, human resources and business engagement, Jenn oversees day-to-day operations of PerceptiMed while evangelizing the benefits of its VeriFill products. Prior to co-founding PerceptiMed, Jenn handled sales and marketing for Perseid Professional Services, a private consulting firm. She also provided executive financial services, strategic business management consulting and infrastructure creation for both start-up and established high tech companies. Previously Jenn served as the business development officer at Greater Bay Bank, which was a community bank subsidiary of Greater Bay Bancorp (acquired by Wells Fargo 2008). She is credited with closing more than $20 million in annual sales. Prior to that she was vice president and COO for Ulta.com, an on-line initiative for Ulta, Inc. She has also served in various controller positions at Interwise, Inc.; Metromedia Fiber Networks; and Associated Venture Networks. She has also served as an accountant for Arthur Anderson, LLC, and Price Waterhouse, LLC. Jennifer received a bachelor’s of science degree in accounting, cum laude, from the University of Maryland. She additionally holds a CPA and a certificate in mediation from The University of California at Berkeley.
Follow Jennifer Jacob:
About PerceptiMed: PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Aadil Diwan
Co-Founder & CTO of SafKan Health
Follow Aadil Diwan:
About SafKan Health: Ear care for the 21st century.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Nevada Sanchez
Co-Founder, ASIC Design Lead of Butterfly Network
Nevada Sanchez is a co-founder of [Butterfly Network](https://www.crunchbase.com/organization/butterfly-network#/entity). Previously, he was an FPGA developer and hardware engineer at Massachusetts Institute of Technology. Sanchez holds a bachelor’s degree in mathematics and master’s degree in engineering from Massachusetts Institute of Technology. He lives in Branford, Connecticut, United States.
Follow Nevada Sanchez:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Andrew Song
President and Co-Founder of Whisper
Andrew Song is the President and Co-Founder at Whisper.
Follow Andrew Song:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Shlomo Zippel
Co-Founder of Whisper
Follow Shlomo Zippel:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Seth Harrison
Founder & Managing Partner of Apple Tree Partners
Seth Harrison is the managing partner of Apple Tree Partners and serves as Executive Chairman of Braeburn Pharmaceuticals. He has invested in life sciences since 1991. Seth has served as founding investor, acting CEO or chairman of numerous portfolio companies. He is currently also Chairman of Tokai Pharmaceuticals, Chairman of Aileron Therapeutics and Deputy Chairman of Heartware International, all companies he founded. Prior to founding ATP, Seth was a general partner at Oak Investment Partners and earlier was a venture partner at Sevin Rosen Funds. His prior investments include: ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, Informed Access, SGX Pharmaceuticals, Ultracision and ViroPharma. Seth received an A.B. from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at the Presbyterian Hospital in the City of New York. From 2002 – 2010 he served on the board of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation sponsored public-private partnership engaged in the development of anti-HIV microbicides.
Follow Seth Harrison:
About Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
James C. Katzaroff
CEO, Chairman and Founder of Vivos Inc
A serial entrepreneur who started his first company importing minerals and pewter from Brazil while in high school in southern California, Mr. Katzaroff is constantly searching for outstanding opportunities. Hired straight out of college Mr. Katzaroff was a financial consultant for Wall Street firms Bateman Eichler, Smith Barney and EFHutton. Since 1990, he has been responsible for corporate engineering, senior-level corporate strategy, fostering investment bank relationships, and has served as a senior financial advisor for numerous start-ups and development stage companies. A strong desire to make an unshakable impact in the fight against cancer led Mr. Katzaroff to found AMI in 2006.
Follow James C. Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Ray Shealy
Co-Founder of Noxsano
Follow Ray Shealy:
About Margaux Capital, Noxsano, SeatCycle: Noxsano Inc. is developing a device to treat chronic wounds.
Stevan Samuel
Co-Founder of Noxsano
Stevan has extensive experience in product development with two years in product development at P&G and five years utilizing open innovation and lean startup principles to help Fortune 500 companies build scaleable businesses.
Follow Stevan Samuel:
About Noxsano: Noxsano Inc. is developing a device to treat chronic wounds.
Jacob Adams
Co-Founder of Noxsano
Jacob has spent the past eight years as a scientist at P&G developing activated technologies providing point-of-use benefits to consumers.
Follow Jacob Adams:
About Noxsano, Procter & Gamble Company: Noxsano Inc. is developing a device to treat chronic wounds.
Wei-Wu He
Founder and CEO of Origene Technologies
Wei-Wu He is a biotech executive dedicated to the commercialization of innovative life sciences technologies for the healthcare market.He is currently Chairman and CEO of OriGene Technologies, Inc. He is also the founder and General Partner of Emerging Technology Partners, LLC (ETP), a venture firm dedicated to incubating innovative life sciences companies. He is also a Venture Partner of IDG/Accel Partners, a $4 Billion venture fund designed to fund innovative companies in China.He started his biotech career as a scientist at the inception of Human Genome Sciences, Inc.He has been involved in the funding and founding over 20 biotech companies throughout his career and has served on many biotech company boards. Most recently He was named the Executive Chairman of Casi Pharmaceuticals, a biotech company dedicated to the development of innovative cancer treatments both in China and the US.He has conducted cancer research at Mayo Clinic and at Massachusetts General Hospital as a research fellow. He has been awarded over 30 United States patents and has more than 25 original research publications.He received a Bachelor’s degree in Biochemistry from Nanjing University, P. R. China, an M.B.A. from Wharton School of the University of Pennsylvania, and a Ph.D. in Molecular Biology from Baylor College of Medicine.
Follow Wei-Wu He:
About Emerging Technology Partners, Origene Technologies: OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
Rhodemann Li
Founder, EVP Strategy & Finance of Vesselon
Mr. Li is the founder of Vesselon and is a serial medical device entrepreneur and brings more than thirty years of experience in finance, business development, strategy, patents and regulatory submissions. Prior to founding Vesselon in 2012, Mr. Li worked in private equity evaluating investment opportunities. Mr. Li co-founded an orthopedic implant company, Li Medical Technologies, which developed and sold sports medicine surgery and spinal implants. Li Medical was venture capital funded and ultimately acquired by ConMed Corporation. Mr. Li has five issued patents for medical devices. Mr. Li also worked for FMR Group, an investment vehicle for healthcare investors, and Golden Pond Healthcare, a special purpose acquisition corporation formed to assume a healthcare company, where he sourced investment opportunities. Prior to his healthcare experience, Mr. Li was a Vice President in Corporate Finance at UBS Securities and a Vice President in Corporate Lending at Manufacturers Hanover. Mr. Li holds a B.A. from Middlebury College and an M.B.A. from the University of Chicago.
Follow Rhodemann Li:
About Accelerator for Biosciences in Connect, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Steve Gorlin
Founder of Hycor Biomedical LLC
In January 2014, Mr. Gorlin joined the Company as its Executive Chairman. Over the past 40 years, Mr. Gorlin has founded several biotechnology and pharmaceutical companies, including Hycor Biomedical, Inc. (acquired by Agilent), Theragenics Corporation (NYSE: TGX) , CytRx Corporation (NASDAQ: CYTR), Medicis Pharmaceutical Corporation (sold to Valeant for approximately $2.6 billion), EntreMed, Inc. (NASDAQ: ENMD), MRI Interventions (MRIC) , DARA BioSciences, Inc. (NASDAQ: DARA), MiMedx (NASDAQ: MDXG), and Medivation, Inc. (NASDAQ: MDVN). Mr. Gorlin has served on the Business Advisory Council to the Johns Hopkins School of Medicine and has previously served on The Johns Hopkins BioMedical Engineering Advisory Board. He also serves on the Board of the Andrews Institute. He founded a number of non-medical related companies, including Perma-Fix, Inc., Pretty Good Privacy, Inc. sold to Network Associates, Judicial Correction Services, Inc. sold to Correctional Healthcare, and NTC China. He started The Touch Foundation, a nonprofit organization for the blind and was a principal financial contributor to the founding of Camp Kudzu for diabetic children. He presently serves as the Executive Chairman of DemeRx, Inc., and serves on the Board of NTC China, Inc.
Follow Steve Gorlin:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Jeff Dachis
Founder, Chairman & CEO of One Drop
After Jeff Dachis was diagnosed with type 1 diabetes, he set out to create a data-driven digital platform that would disrupt the reactive healthcare model. In 2015, One Drop was born. The precision health company combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people worldwide living with diabetes and other chronic conditions.
Next, One Drop plans to enter the market with a daily disposable, minimally invasive continuous health sensor in development designed to provide greater flexibility and insights for people living with diabetes compared to fingersticks alone. The availability of this proprietary sensor is subject to receipt of clearance or approval from the U.S. FDA. Before One Drop, Dachis co-founded Razorfish (NASDAQ: RAZF) and led its $55MM IPO, then founded the Dachis Group (acquired by Sprinklr).
Dachis has appeared on Crain’s 40 Under 40 list and was named EY Entrepreneur of the Year. An internet pioneer, having helped create the first banner ad and web animation, Dachis now channels his passion for data, technology, and design at One Drop, building data-driven products that empower people to take charge of their health.
Follow Jeff Dachis:
About One Drop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Marc Korczykowski
CEO and Co-Founder of Hura Imaging
Marc Korczykowski is Hura Imaging’s Co-Founder and CEO.
Follow Marc Korczykowski:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Danny JJ Wang
CSO and Co-Founder of Hura Imaging
Danny JJ Wang is the Co-Founder and Chief Science Officer of Hura Imaging.
Follow Danny JJ Wang:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Michael Bartholomew
Co-Founder, Inside Director & Chief Commercial Officer of Promaxo
Mr. Michael Bartholomew is the EVP and Chief Commercial Officer at Promaxo. He has broad therapeutic experience across nearly twenty diseases covering large and small molecules, medical devices and diagnostics. Michael manages the go to market strategy, voice of customer, partner relationships and tactical implementation relating to corporate infrastructure. Prior to Promaxo, Michael was a Principal at Porzio Life Sciences, as well as Vice President of Sales & Marketing for Dohmen Life Science Service, where he developed and launched several commercial initiatives achieving sustained sales growth. Before Dohmen, he served in various sales and brand leadership positions for Pfizer, Pharmacia and Baxter. Michael proudly served in the US Air Force as a decorated combat aviator, where he achieved the rank of Captain. He received his Masters of Science in Administration from Central Michigan University and his Bachelor of Arts in Economics from Indiana University.
Follow Michael Bartholomew:
About Neuro42, Promaxo: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Harel Gadot
Co-Founder & CEO of Microbot Medical
Harel Gadot is a co-founder of Microbot Medical and has been serving as the CEO since its inception and the Chairman of the Board since 2013. He is also the Chairman of XACT Robotics Ltd., another promising medical robotics company, specializing in the field of needle steering for medical procedures such as biopsies. Until 2013, he was a board member at ConTIPI Ltd. Which was acquired in 2012 by Kimberly Clark. Prior to founding Microbot Medical, he served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches. Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel. He is a guest speaker for management and innovation courses at leading universities in the United States and Israel, and holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).
Follow Harel Gadot:
About MEDX Ventures Group, MEDX Xelerator, Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
Kristina Cahojova
Founder & CEO of kegg
Kristina Cahojova is the Founder and CEO of Kegg.
Follow Kristina Cahojova:
About kegg: Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising.
Matthew Putman
Co-Founder & Chief Executive Officer of Nanotronics Imaging
Matthew Putman Co-Founded Nanotronics Imaging, LLC in 2008 and serves as its Chief Executive Officer. Matthew Putman is a Professor and Researcher at Columbia University. He was an owner and Vice President of Development for Tech Pro, Inc., which was acquired by Roper Industries in March 2008. During his time at Tech Pro, he lead two acquisitions, and the transformation of the instrument manufacturer into new global markets, having formed partnerships or subsidiaries in 15 nations. He serves as a Director of Nanotronics Imaging, LLC. He has lectured at The University of Paris, USC, University of Michigan, and The Technical University of Sao Paulo. He has also produced several plays and films, and is an accomplished composer. He is a founding member of the World Science Festival. He is on the Executive Board of the Montauk Observatory, and is an Artist in Residence for Imagine Science Films. He holds 5 patents, and has published over 20 technical papers, and in 2002 he won the ACS Best Paper Award. He has a Ph.D. in Applied Physics.
Follow Matthew Putman:
About Nanotronics Imaging, The Thiel Foundation: Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
Thomas Oxley
CEO & Founder of Synchron
Thomas Oxley is the CEO at Synchron
Follow Thomas Oxley:
About Defence Science and Technology, Florey Institute of Neuroscience & Mental Health, Mount Sinai Health System, Synchron, Synchron, University of Melbourne, VascuLab: Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
George Palikaras
Founder, President/CEO of Metamaterial Inc.
Founder at Metamaterial Technologies
Follow George Palikaras:
About Metamaterial Inc.: Mastering Light using Smart Materials & Photonics. Changing the way we use, interact and benefit from Light.
Vivek Kopparthi
CEO, Co-Founder & Executive Chairman of NeoLight
Vivek Kopparthi is Co-founder & CEO of NeoLight, a lean medical device start-up developing a disruptive technology to treat Jaundice in infants.
Follow Vivek Kopparthi:
About NeoLight, PriZm Therapeutics: Neolight is a medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies.
Yulun Wang
Founder, Chairman & Chief Innovation Officer of InTouch Health
Yulun Wang, Chairman, Founder & Chief Innovation Officer, InTouch Health, Inc. Dr. Wang founded InTouch Health in 2002, and served as Chairman & CEO until 2016, when he assumed the position of Chairman and Chief Innovation Officer. InTouch Health is a pioneering and market leading telehealth company that enables patients to receive clinical care from specialists at a distance. InTouch has received numerous awards including Deloitte’s Technology Fast 500 Award and Inc Magazine’s Inc 500 award as one of the fastest growing companies in America. Previous to InTouch, Dr. Wang founded Computer Motion in 1990, the company which pioneered surgical robotics. He was the principal architect and inventor of the voice-controlled robotic arm called AESOP, the first FDA-cleared surgical robot, as well as the ZEUS robotic surgical system, which performed the world’s first transatlantic surgery. Computer Motion IPO’d in 1997 and merged with Intuitive Surgical (NASD: ISRG) in 2003 for one third of the resulting company. Dr. Wang is author to more than 50 technical publications and inventor on over 100 patents.
Follow Yulun Wang:
About InTouch Health: InTouch Health is the leader in Acute Care Telemedicine solutions.
Rishi Shah
Founder & Chairman of Outcome Health
Rishi Shah is the Founder and Chairman at Outcome Health.
Follow Rishi Shah:
About Home Chef, Jumpstart Ventures, Outcome Health, Pritzker Group Venture Capital: Outcome Health delivers better health outcomes and impacts the human condition positively through technology.
Rodney Perkins
Founder and Chief Medical Officer of Earlens
Rodney Perkins, the Founder and Chief Medical Officer of EarLens, is a serial entrepreneur who has successfully launched many healthcare technology companies including ReSound Corporation, Laserscope, Collagen Corporation, Sound ID, Novacept, SurgRx, DFine, Pulmonx and Cohesion.As an internationally known otologic surgeon, he has created a number of surgical procedures and techniques that are widely practiced throughout the world. Dr. Perkins founded the California Ear Institute at Stanford and is a Clinical Professor of Surgery at Stanford University School of Medicine. For his visionary leadership that has lead to innovation in multiple medical specialties, Dr. Perkins has received the Phoenix Hall of Fame Innovators Award, Lifetime Achievement Awards from the Santa Clara County Medical Society and the Distinguished Medical Alumnus Award from Indiana University. Dr. Perkins holds eighteen issued patents with 37 pending, received his medical degree from Indiana University, and completed his surgical residency at Stanford University School of Medicine.
Follow Rodney Perkins:
About DFine, Earlens, Pulmonx: Earlens is a privately held medical technology company transforming the hearing experience with the only direct sound delivery system.
Daniel Burnett
Founder and Chairman of Bone Health Technologies
Dr. Burnett has a long history of biomedical device design and testing. After graduating from University of Pennsylvania’s school of Bioengineering, Dr. Burnett spent a year at the Food and Drug Administration both testing devices and writing congressional reports on the current state-of-the- art devices. Following receipt of his MD and MBA degrees from Duke University, Dr. Burnett completed his one-year internship at the Mayo Clinic in Jacksonville, FL and is currently a licensed physician in the state of California. After working for two years as a General Partner with MedVenture Associates, a medical device venture capital firm in Emeryville, CA, Dr. Burnett left the firm in 2006 and committed himself to TheraNova and its subsidiaries.
Follow Daniel Burnett:
About Ananya Health, Anathem Ventures, Bone Health Technologies, Channel Medsystems, Consano, Gravitas Medical, Perikinetics, Potrero Medical, Respirix, TheraNova LLC., University of California, San Francisco: Bone Health Technologies is developing a new standard of care for treating both osteoporosis and osteopenia, the precursor to osteoporosis.
Shantanu Gaur
Co-Founder & CEO of Allurion Technologies
Shantanu Gaur co-founded Allurion in 2009 during his second year at Harvard Medical School and is our Chief Scientific Officer. A Paul & Daisy Soros Fellow, Shantanu graduated summa cum laude and Phi Beta Kappa from Harvard College with an S.B. in Biology and significant coursework in polymer chemistry. Shantanu graduated from Harvard Medical School in 2013. He grew up in Pittsburgh, Pennsylvania and lives in Cambridge, Massachusetts.
Follow Shantanu Gaur:
About Allurion Technologies, Genetic Alliance: Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Steven McKnight
Founder of Peloton Therapeutics
Follow Steven McKnight:
About Flare Therapeutics, Peloton Therapeutics, Tularik, University of Texas Southwestern Medical School: Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Jerry Bryant
Founder, Managing Member & CTO of Cell Point
Jerry Bryant, Jr., is a founding member of Cell>Point, the CTO and has been providing financial support to the company since its beginning. Mr. Bryant is also President and Managing Member of Vyripharm Biopharmaceuticals, a majority owned subsidiary of Cell>Point. Mr. Bryant brings 15 years in research experience in molecular biology, imaging and oncology. Prior to the establishment of Cell>Point, Mr. Bryant worked as a research assistant from 1994 through 1999 in the Department of Medicine, Division of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center. During 1999 and 2000, Mr. Bryant served as President of Allcure JEMA, Inc. Mr. Bryant received his B.S. from Tennessee State University in 1987 and M.S. from the University of Florida in 1991.
Follow Jerry Bryant:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Terry Colip
Founder, Managing Member & CFO of Cell Point
Terry Colip, the Founder of Cell>Point, was a founding member of the firm and has provided his expertise from its inception. Mr. Colip has 26 years of expertise in investment banking and venture capital in the healthcare industry. Prior to founding Cell>Point, Mr. Colip worked as a healthcare consultant for Coopers & Lybrand in New York. He provided equity and investment banking services for roughly $2 billion in healthcare transactions at Underwood Neuhaus & Co., Boettcher & Co., and American Health Capital, Inc. Mr. Colip was also a founding partner in Chewton Glen Energy L.L.C. This company built two electric power plants in Illinois. Many media outlets, including Fox Business Network, Fox News, NBC News Denver, ABC News Denver, CBS News Denver, and National Public Radio, have highlighted Mr. Colip. Mr. Colip earned a B.S.I.E. in 1979 from the University of Wisconsin’s College of Engineering and an M.P.A. in finance and healthcare administration from New York University in 1981. Mr. Colip donates his time and resources to charities and organizations that focus on healthcare and disability outreach.
Follow Terry Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Greg Colip
Founder, Managing Member & CEO of Cell Point
Since its beginning, Greg Colip is a founding member of Cell>Point and has provided financial support to the company. Mr. Colip brings over 38 years of experience in healthcare marketing and legal. Prior to establishing the company with Jerry Bryant and Terry Colip, Mr. Colip was a corporate mergers and acquisition lawyer and served as Deputy General Counsel for Panhandle Eastern Corporation (which has since been split up with part of the company’s subsidiaries owned by Duke Energy and the remaining part-owned by CMS Energy), provided legal counsel and development work for various independent power projects, served as Vice President and General Counsel for the Gulfco Division of Chromalloy American Corporation and was a production/marketing manager for The Upjohn Company (now part of Pharmacia). At Panhandle Eastern, Mr. Colip was involved in numerous complex venture, merger, spin-off, and acquisition transactions, including the $2.4 billion acquisition of Texas Eastern Corporation and the $1.2 billion drop down and spin-off of Anadarko Petroleum Corporation. At Upjohn, Mr. Colip was the production/marketing systems manager for the corticosteroid and anticoagulant product lines. Mr. Colip received his bachelor’s degree in production management and industrial engineering in 1970, followed by his M.B.A. two years later and a J.D. in 1978. His higher education was at Indiana University, and Greg is proud to call it his Alma Mater.
Follow Greg Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Leonide Saad
Founder, President & Chief Executive Officer of Alkeus Pharmaceuticals
Dr. Saad founded Alkeus Pharmaceuticals with the goal of developing sight-saving, transformative medicines for the most serious and untreatable causes of blindness. Prior to Alkeus, he was partner in a boutique life sciences management and consulting firm in New York City, providing business and strategic guidance to biotechnology and pharmaceutical companies. He was previously at Proteus Venture Partners, an early stage, California based venture fund focused on stem cells and regenerative medicine. Dr. Saad holds a PhD focused on tissue engineering from MIT, a certificate of Financial Technology from MIT Sloan School of Management, a MS in Mechanical Engineering from MIT, a BS and MS in Applied Mathematics from University of Paris VI, and is a graduate from Ecole Polytechnique, Paris, with a concentration in organic chemistry and physics.
Follow Leonide Saad:
About Alkeus Pharmaceuticals: Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic conditions.
Daniel Shen
Founder and Chief Clinical and Science Officer of Eargo
Daniel is a Founder and the Chief Clinical & Science Officer of Eargo. Brilliant, logical, curious, he’s our Mr. Spock, but way more fun at parties. Daniel is a lifelong entrepreneur who’s co-founded three medical device companies and holds numerous patents. Plus, he holds degrees from MIT and studied medicine at Stanford. He’s also an avid scuba diver and kite boarder, so we’re assuming he can swim. Leading our Clinical Research department, he’s ensuring that Eargo boldly goes where no hearing aid has gone before…we’re waiting for him to invent di-lithium crystals.
Follow Daniel Shen:
About Eargo: Eargo makes direct-to-consumer hearing aids, allowing customers to access help for their hearing loss from their homes.
Elon Boms
Founder, Board of Directors of LaunchCapital
Elon Boms co-founded LaunchCapital in January 2008 to help entrepreneurs gain quick access to seed capital and mentorship. With a passion for working with industry disruptors and teams that have a strong business development focus, Elon has been involved in over 75 deals across a wide range of industries and geographies. He holds an MBA from Yale School of Management and a BA in Economics from George Washington University. His prior work experience includes brand management, strategy consulting and finance. Elon lives in Connecticut with his wife, newborn daughter, and very shaggy dog.
Follow Elon Boms:
About LaunchCapital: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
Konstantinos Alataris
Founder, CEO of Nesos
Konstantinos Alataris is the President and CEO of the Nevro Corp. Prior to founding Nevro, Dr. Alataris was a venture capitalist with Bay City Capital in San Francisco, focusing on investment and strategic advisory services. He was previously a Business Development Manager with Compass, Guidant’s Corporate Venturing Group, where he analyzed and structured medical device/healthcare investments and evaluated acquisition targets. He was also a Research Fellow at the House Ear Institute, a research center and clinic in Los Angeles. Dr. Alataris holds a Ph.D. in Biomedical Engineering, an MBA, and an M.S. in Electrical Engineering from the University of Southern California. He received a BS in Electrical Engineering and Computer Science from the National Technical University of Athens, Greece.
Follow Konstantinos Alataris:
About Nesos: Nesos develops wearable interfaces and software components for the treatment of neurological disorders.
Cameron Teitelman
Founder, Chairman, and head of admissions and oversee investment vehicles of StartX (Stanford-StartX Fund)
Cameron Teitelman is the Founder and Chairman of StartX, a 501 (c)(3) nonprofit that runs an accelerator for Stanford affiliated entrepreneurs. Under his management, StartX has supported more than 1,100+ founders building 500+ companies. StartX companies have raised over $3.3B to date. In 2013, the Stanford-StartX Fund was launched. To date, SSF has invested in 250 StartX companies across 400+ rounds, investing $130 million in capital.
Follow Cameron Teitelman:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Dan Ha
Co-Founder, Sr. Managing Director of StartX (Stanford-StartX Fund)
Follow Dan Ha:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Martyn Gross
Co-Founder & CEO of Zerigo Health
Advisor at Cooler Heads Care & Chief Business Officer at Mindera.
Follow Martyn Gross:
About Dthera Sciences, MiNDERA Corporation, Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Remo Moomiaie-Qajar M.D.
Co-Founder of Zerigo Health
Dr. Moomiaie-Qajar is a trained surgeon from Yale University with a long academic history of innovating technologies in medicine and translating them into commercially viable products. Dr. Moomiaie-Qajar has 15 years of experience incubating technologies from start-up or early stage level to exit. His background as an academic researcher, physician, and entrepreneur brings an unique trifecta of perspective and experience to Cytonus. He holds a number of US and International Patents and has successfully funded and launched a number of Life Science companies. He is the past CEO of Remo CRO, a full service CRO and Dr. Moomiaie-Qajar is an active member of a number of National Angel Investment Groups and manages a Life Science seed fund.
Follow Remo Moomiaie-Qajar M.D.:
About Remo Life Science, Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Remo Qajar
Co-Founder of Zerigo Health
Remo Qajar is the Co-Founder and Chief Innovation Officer at Skylit Medical. Remo’s postgraduate career as an academic researcher and trained Surgeon at the Yale School of Medicine led him to invent a number of medical devices, from implantable respiratory diaphragms to orthopedic and wound care products, some of which have been spun-off into companies. Remo is the founder of InQMEDS LLC. an accelerator of growth for early stage life-science products.
Follow Remo Qajar:
About Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Julia Taylor Cheek
CEO and Founder of EverlyWell
Julia Taylor Cheek is the CEO and Founder of EverlyWell, a digital health startup empowering consumers to order, self-collect, and understand lab tests. Based in Austin, EverlyWell launched in June 2016 after raising $3M in capital and garnering awards from Tech Crunch and Rock Health. They now have over 5,000 customers in 46 states. Julia was also named the number one female entrepreneur to watch by CIO magazine for 2017. Prior to founding EverlyWell in 2015, Julia was the Vice President of Corporate Development and Strategy at MoneyGram International, a public financial services company that operates in 200 countries. As the youngest VP in the company, she worked for MoneyGram’s CFO for several years, leading corporate transactions, restructuring projects, and special projects for the CEO. Before that, she served as the founding Director of Strategy and Operations at the George W. Bush Institute and played a key role in building the organization from just a handful of employees to the Presidential Center that you see today at Southern Methodist University. After attending Vanderbilt, Julia started her career in management consulting at Deloitte and went on to earn her MBA from the Harvard Business School, where she graduated as a Baker Scholar with high distinction. She also is a former multiple World Champion equestrian, officially retiring in 2009.
Follow Julia Taylor Cheek:
About EverlyWell: EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
Connor Landgraf
Co-Founder & CEO of Eko Health
Connor Landgraf is the co-founder and CEO of Eko.
Follow Connor Landgraf:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Jason Bellet
Co-Founder, Chief Strategy Officer, Board Member of Eko Health
Follow Jason Bellet:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Tyler Crouch
Co-Founder, VP of Mobile Engineering & Product Development of Eko Health
Follow Tyler Crouch:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Wenbin Jiang
Co-Founder and CEO of Cytek Biosciences
Wenbin Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Follow Wenbin Jiang:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Ming Yan
Co-Founder and CTO of Cytek Biosciences
Ming Yan is a co-founder of Cytek Biosciences, Inc. with over 20 years of R&D experience in leadership and innovation. Prior to Cytek, Ming Yan held research and development positions at AT&T Bell Laboratories, Lawrence Livermore National Labs and BD Biosciences. He is one of the thought-leaders in flow cytometry instrumentation and standardization. Ming Yan has published several research papers relating to laser spectroscopy and cell analysis in top peer-reviewed journals. He has over a dozen patents and patent pending applications for his innovations.
Follow Ming Yan:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Lixiao Wang
Founder, Chairman, and Board of Directors of Urotronic
Lixiao Wang is the Founder, Chairman, and Board of Directors of Urotronic, Inc.
Follow Lixiao Wang:
About Urotronic: A Minnesota based, medical device company, making an exciting innovation in urethral stricture treatment.
Cliff Illig
Co-Founder of Cerner
Cliff Illig, vice chairman of the board and co-founder of Cerner, focuses on growing and expanding Cerner’s market-oriented business units, key strategic relationships and priority corporate initiatives. Illig previously served as chief operating officer until October 1998 and as president until March 1999. Illig’s keen business sense was instrumental in the company’s initial public stock offering in 1986, secondary public offering in 1995 and three two-for-one stock splits in the 1990s. Illig served as the initial force behind Cerner’s internal operations, including its leading-edge communication and information systems technology, client service methodologies, and sales and marketing strategies. He recognized early on that the ability to communicate and share information within the enterprise is as essential to Cerner as it is to any of its clients. Under Illig’s leadership, Cerner set a standard for the use of enterprise-wide technology to achieve seamless communication and information sharing throughout the organization. He also played a key role in the design of the Cerner Millennium® architecture, which uses advanced technologies to automate the process of managing health along the full continuum of care. Cerner Millennium collects clinical data as a by-product of the care process for use in electronic medical records and for benchmarking outcomes. The Cerner Millennium architecture also enables Cerner clients to benefit from a seamless flow of clinical information across multiple clinical disciplines and among geographically diverse locations. Currently, Illig serves as a member of the Executive Committee of the Heart of America Council of Boy Scouts of America. In addition, he and Cerner Chairman and CEO Neal Patterson, along with others, are co-owners of Kansas City’s Major League Soccer franchise, Sporting KC. He is also a member of the board of directors of the Stowers Institute. In 1991, the Ernst & Young accounting firm honored Illig and Patterson as Entrepreneurs of the Year. Prior to co-founding Cerner in 1979, he was a system consultant and manager with Arthur Andersen & Co. in Kansas City, Mo. He is a graduate of the University of Kansas with a degree in accounting and business administration.
Follow Cliff Illig:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Neal Patterson
Co-Founder of Cerner
Neal Patterson is chairman of the board and chief executive officer of Cerner, a company he co-founded with two colleagues in 1979. Today Cerner is the world’s largest independent health information technology company with $3.4 billion in revenues in 2014 and more than 21,000 associates worldwide. In 2015, Cerner was ranked by Forbes as one of the “World’s Most Innovative Companies” and by Fortune as one of the “World’s Most Admired Companies.” Widely respected for his vision and strategic thinking, Patterson has a unique ability to anticipate and articulate how information technology will transform health care. Starting with a single laboratory information system in 1979, by the mid-1980s, Patterson was investing in creating a suite of fully integrated, clinically focused commercial health care applications. Cerner entered the 1990s with a first of-its-kind application set built on a common platform with real-time interactive decision support. In the mid-1990s, Cerner invested significant resources to rebuild the platform on client-server technology using a person-centric data model. During his multi-decade tenure as CEO, Patterson has led Cerner to invest more than $4 billion in R&D of health IT, and the solutions Cerner has designed are deployed at more than 18,000 health care facilities in more than 30 countries. As a public company, Cerner has outperformed the broader markets since its inception and today is listed on the S&P 500 and NASDAQ-100 indexes. Patterson is co-founder and serves on the executive board of the First Hand Foundation, a non-profit foundation that provides assistance to children with critical health care needs. He serves as a Lifetime Director for the 116-year-old American Royal Association celebrating agrarian lifestyles and values, and he gives time to support the development of other entrepreneurs. He and Cerner co-founder Cliff Illig, along with others, are co-owners of Kansas City’s Major League Soccer franchise, Sporting KC. Patterson grew up on his family’s farm near Manchester, Okla. He earned a bachelor’s degree in finance and master’s degree in business administration from Oklahoma State University.
Follow Neal Patterson:
About Cerner, First Hand Foundation: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Behrooz Abiri
CTO and Co-Founder of GuRu
A hardware hobbyist and International Physics Olympiad gold medalist – Behrooz has always been an avid inventor. He’s spent his life studying, learning, and exploring emerging technologies. His work at GuRu stems from a wish to share miraculous technology with the world at large. At GuRu, Behrooz is responsible for the ongoing development of core technology and system architecture. Under his leadership, GuRu’s millimeter-wave technology has been developed into an accessible consumer product. Before GuRu, Behrooz helped develop system design and architecture in Caltech’s Space Solar Power Initiative. He holds a Ph.D. in Electrical Engineering from Caltech.
Follow Behrooz Abiri:
About GuRu: Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Florian Bohn
CEO & Co-Founder of GuRu
Florian has always felt compelled to understand the way the world works. His curiosity moved him to study Electrical Engineering at Caltech (B.S. Cum Laude), to receive an M.S. in Electrical and Computer Engineering from UC Santa Barbara, and a Ph.D. in Electrical Engineering from Caltech. At GuRu, Florian is thrilled to be building technology that will enrich people’s lives on a global scale. He is also proud to be building a community of passionate and like-minded engineers at the organization. As a co-founder and CEO at GuRu, Florian brings years of technology experience. At Axiom Microdevices, he helped define and implement high-frequency RF integrated circuits which have shipped more than 400 million units. At Agilent Laboratories (formerly HP Labs) he worked on clock and data recovery circuits as well as novel test and measurement systems. As a Caltech Lead Scientific Researcher, Florian guided engineering and operational aspects of implementing the microwave system at Caltech’s Space Solar Power Initiative.
Follow Florian Bohn:
About GuRu: Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Benjamin Kruger
Co Founder of Sollis Health
Ben Kruger operates out of Vandewater’s Los Angeles office, sourcing and analyzing new business opportunities while managing preexisting investments within the company’s diverse portfolio. Ben contributes a majority of his time to Vandewater Media where he leads its Content and Creative team. Before joining Vandewater, Ben was the Creative Director of Jesta Digital. Ben has also contributed as a writer and producer for ABC Studios and Paramount Pictures. Kruger holds a bachelor’s degree in History from Brown University and is the recipient of a History Research Fellowship from St. Edmund Hall at Oxford University, UK.
Follow Benjamin Kruger:
About Sollis Health: Sollis Health offers 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.
Dr. Bernard Kruger
Founder of Sollis Health
Board-certified in Oncology and Internal Medicine and on faculty at Weill Cornell, Dr. Kruger has been serving the needs of his patients for more than 30 years from his office in Manhattan’s Upper East Side. As a pioneer of concierge medicine, Dr. Kruger has devoted his career to making the doctor–patient relationship as comfortable, reliable and easy as possible.
Follow Dr. Bernard Kruger:
About Sollis Health: Sollis Health offers 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.
Andrew Olanow
Founder of Sollis Health
A passionate advocate for improvements in the healthcare industry, Andrew has been a healthcare investor and analyst for more than 10 years at Generation IM, Morgan Stanley and Merrill Lynch. He has consulted for many health systems and advised multinational institutions toward more effective and efficient healthcare models. Andrew holds an MBA from London Business School and a BA from Columbia University.
Follow Andrew Olanow:
About Sollis Health: Sollis Health offers 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.
Carlito Lebrilla
Co-Founder of Evolve Biosystems
Carlito B. Lebrilla is a Distinguished Professor at the University of California, Davis in the Department of Chemistry and Biochemistry and Molecular Medicine in the School of Medicine. He received his BS degree from the University of California, Irvine and Ph.D. from the University of California, Berkeley. He was an Alexander von Humboldt Fellow and a NSF-NATO Fellow at the Technical University in Berlin. He returned to the UC Irvine as a President’s Fellow and has been at UC Davis since 1989. He has served as Chair of the Chemistry Department. His research is in Analytical Chemistry, primarily mass spectrometry with applications to clinical glycomics and biofunctional food. He has over 320 peer-reviewed publications. He is also co-editor of Mass Spectrometry Reviews and has been on the editorial board of Molecular and Cellular Proteomics, Mass Spectrometry Reviews, Journal of American Society for Mass Spectrometry, European Mass Spectrometry, and International Journal of Mass Spectrometry.
Follow Carlito Lebrilla:
About Evolve Biosystems, InterVenn: Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.
Daniela Barile
Co-Founder of Evolve Biosystems
Daniela Barile is Associate Professor at the University of California Davis. She received her degrees in the area of Pharmaceutical Chemistry and Food Science from the Piemonte Orientale University (Italy). Her research, focused at the nexus of food, health, and the environment, aims to understand food bioactive compounds formation, their recovery from food production side streams, and their specific interactions within the human body. Her lab utilizes analytical platforms based on mass spectrometry to investigate foods and a range of relatively untapped organic waste streams for valuable, healthful bioactive compounds (such as free oligosaccharides, peptides, glycoproteins and glycolipids). Her approach of sequential molecular deconstruction of food streams is generating valuable bioinformatic libraries of source materials and the underlying biological and processing conditions that give rise to their formation/preservation.
Follow Daniela Barile:
About Evolve Biosystems, University of California Davis, University of California Davis: Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.
Richard Lin
CEO & Co Founder of Ombre
Follow Richard Lin:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Jun Kim
CSO & Co Founder of Ombre
Follow Jun Kim:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
William Herlands
CEO and Co-Founder of Willow
Will Herlands is the CEO of Willow. After graduating from Princeton University where he studied electrical engineering, Will worked at MIT Lincoln Laboratory conducting research on AI, robotics, and cybersecurity. He then entered a dual PhD in Machine Learning and Public Policy at Carnegie Mellon University, focused on helping policy makers and create more effective, intelligent, and just decisions. In 2017 he took these analytical approaches to help develop a novel way of providing stylish, affordable, and convenient adult incontinence products, allowing people to live proud and in style without losing their wallets.
Follow William Herlands:
About Willow: Willow is stylish, comfortable, affordable disposable underwear — delivered discreetly to your door at a fraction of the price.
Christopher McCann
CEO & Co-Founder of Current Health
I left school at the age of 16 and graduated with a Masters in Computer Science at age 21. At 20, I set up my first company, Dizeo – this was in social networking for children. This failed in 2011 but the experience taught me some of the most valuable lessons of my life. Around the same time, I was spending time in hospitals due to an unwell relative. I decided to go to medical school as a result in 2012. In 2014, I founded snap40 as a direct result of my experiences working in hospital. I was part of the care of patients who had deteriorated avoidably because the warning signs were detected late. I wanted a world where myself and my family would be treated preventatively at the earliest possible point. snap40 prevent illness by automatically detecting those at high risk. We’re a software company who uses our own wearable device, worn on the upper arm of the patient, to continuously monitor them. We then do predictive analytics to identify the patient who needs medical attention most and bring healthcare to them, far earlier. Please get in touch! E-mail: christopher@snap40.com
Follow Christopher McCann:
About Current Health: We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
Gibb Clarke
CEO and Co-Founder of Blockade Medical
Gibb Clarke is co-founder and CEO of Blockade Medical and has more than 10 years experience as a medical device executive with a specific focus on new technology development for the interventional neurovascular marketplace. Prior to co-founding Blockade, Gibb co-founded Pulsar Vascular, Inc. in 2006. A novel therapeutic approach for challenging and complex cerebral aneurysms. Gibb successfully raised multiple rounds of venture capital as well as helped craft and manage the clinical and regulatory strategy for both CE Mark and US approvals. Prior to Pulsar, Gibb played a critical early role in helping Swedish Medical Center in Seattle, WA, plan for and execute the development of The Seattle Neuroscience Institute, a neuroscience center for excellence. Gibb’s efforts resulted in Swedish Medical investing in excess of $35M into the development of its now flagship neuroscience center located in Seattle, WA. Gibb also spent 8 years in the US Marines Corps serving as a team leader in the elite Marine Recon unit. Military schoolings include Amphibious Recon Course, Army Ranger School, US Navy Dive School, and Army Jump School. Gibb is an avid endurance athlete, having competed in over 200 races.
Follow Gibb Clarke:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Rushika Fernandopulle
Co-Founder & Chief Executive Officer of Iora Health
Rushika Fernandopulle is Co-founder and CEO at Iora Health
Follow Rushika Fernandopulle:
About Health Rosetta Group, Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Amir Belson
Founder and CTO of Emboline
Amir Belson Prior to conceiving of and starting ZipLine Medical, Amir Belson, M.D., was the founder of Neoguide Systems, a company that developed platform technology for minimally invasive surgical procedures that was later acquired by Intuitive Surgical in 2009. Belson is also the founder of Vascular Pathways, a company that developed an FDA cleared vascular intervention technology that has been chosen as one of the 10 best inventions of 2009 by Popular Science magazine, Thermocure, a minimally invasive therapeutic hypothermia technology company, Radguard Medical, a radiation protection medical device company and VasoStitch, which develops large vessel access and closure technology. Belson graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford. He also served several years as a flight surgeon in Israel’s air force rescue unit before moving to the US for a three year Pediatric Nephrology fellowship at Stanford University Medical Center. Belson also spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford.
Follow Amir Belson:
About Emboline, Modular Surgical, Qool Therapeutics, Radiaction, Zipline Medical: Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair.
Paul Hindrichs
Co-Founder, CTO of Conventus Orthopaedics
Paul Hindrichs is a veteran business leader and innovator with more than 20 years of medical device experience. He has served in various management capacities during his career, including positions with several other start-up and early stage medical device companies. Prior to founding Conventus, he worked for St. Jude Medical (SJM), Vascular Science, Inc., Optical Sensors, Inc., and Schneider USA (Pfizer). Most recently, he was responsible for the Structural Heart Business and Cardiac Technologies Group at SJM. Mr. Hindrichs earned a Bachelor of Science in Mechanical Engineering from the University of Minnesota and is a named inventor on 20 issued and 22 pending patent applications.
Follow Paul Hindrichs:
About Conventus Orthopaedics, Endogenex: Conventus Orthopaedics is a provider of a range of orthopedic and sports medicine services.
Stuart Hinchen
Co-Founder & CEO of QuVa Pharma
Stuart Hinchen is Founder &CEO @ QuVa Pharma. Stuart Hinchen is currently Chief Executive Officer of JHP Pharmaceuticals, LLC (“JHP”), having acted as President and Chief Operating Officer of JHP from 2007 to 2011. He has been instrumental in the establishment of JHP as a leading injectable pharmaceutical business in the USA. Previously, Stuart was President of Mayne Pharma Americas (“Americas”), a unit of Mayne with $180 million in revenue that was focused on the manufacture, development and sale of generic injectable pharmaceuticals, primarily into the hospital market. Stuart led the Americas activity through a period of significant growth through acquisition, product line extension, and product in-licensing. Having first established Mayne Pharma USA as a stand-alone business, he helped build the division into the fourth largest US generic oncology provider. Prior to his experience with Mayne Americas, Stuart was a General Manager in Mayne’s Mergers and Acquisitions Group, heading transactional and operational teams involved in the purchase, sale and integration of businesses. After joining Mayne in 1995, Stuart worked on a variety of different projects, including the restructuring and sale of the company’s Benelux logistics business to Hays PLC.
Follow Stuart Hinchen:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Peter Jenkins
Co-Founder & Chief Development Officer of QuVa Pharma
Peter Jenkins is Co-Founder & Chief Development Officer at QuVa Pharma.
Follow Peter Jenkins:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Giulio Ruffini
President, CSO and co-founder of Neuroelectrics
Dr. Giulio Ruffini is the CEO and CTO of Starlab and the president and CSO of Neuroelectrics. He obtained a BA in Mathematics & Physics from Berkeley and a PhD in theoretical physics from UC Davis/LANL in 1995. In 2000 he founded Starlab to transform science into high-impact technologies.
12 years later he founded Neuroelectrics, a company which combines high-precision multichannel stimulation technologies with advanced biophysical and neuro-computational models.
For the past 15 years, Giulio has been developing technology for and researching the use of non-invasive brain monitoring and brain stimulation techniques, with a focus on EEG and transcranial current stimulation. His paper on brain-to-brain telepathy communication was the top 10 most shared papers of 2014. He is currently leading or involved in several European programs such as Galvani ERC Synergy, STIPED or Neurotwin.
Follow Giulio Ruffini:
About Neuroelectrics: Neuroelectrics is a digital brain health company that diagnoses and treats brain disorders with personalized neuromodulation, and improves overall brain health.
Kelsey Mellard
CEO & Co-Founder of Sitka
Kelsey Mellard is the CEO and Founder of Sitka, a first-of-its-kind medical vConsults platform and specialty provider network. She launched Sitka in 2018 to help improve access to and delivery of specialty care across the nation. Prior to founding Sitka, Kelsey led Health System Integration at Honor, a comprehensive technology-backed home care company. Before joining the Honor, Kelsey led the development of the Post-Acute Care Center for Research (PACCR), which she served as its Executive Director. Kelsey also served in VP roles at naviHealth, UnitedHealth Group, the Center for Medicare and Medicaid Innovation (CMMI), and held positions at Advisory Board Company, Children’s Mercy Hospitals and Clinics, and Kaiser Family Foundation. Kelsey holds a Bachelor’s of Science Degree in Community Health from Winona State University and a Master’s degree in Public Administration from the University of Kansas. She also currently serves as an adjunct faculty member at Winona State University in the College of Nursing and Health Services.
Follow Kelsey Mellard:
About Sitka, Winona State University: Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.
Jeffrey Thramann
Co-Founder & Director of Lanx
Jeff Thramann is a serial entrepreneur who was the founder and chairman of Lanx, a spinal implant company sold to Biomet, US Radiosurgery, an oncology services company sold to Alliance Healthcare Services (NASDAQ; AIQ), ProNerve, an intraoperative monitoring company sold to Waud Capital Partners and American Physicians, a hospitalist company sold to Towerbrook Partners. Prior to pursuing entrepreneurial endeavors, Thramann was the founder of Boulder Neurosurgical Associates in Boulder, CO. Thramann is the named inventor on over 50 U.S. and international issued and pending patents. He completed his neurosurgical residency and complex spinal reconstruction fellowship at the Barrow Neurological Institute in Phoenix, AZ. Medical school was completed at Cornell University Medical College in NYC and his undergraduate degree was earned at the United States Military Academy at West Point.
Follow Jeffrey Thramann:
About Lanx: Lanx employs its proprietary technology to develop spinal products for surgeons.
Shadi Saberi
Co-Founder & Chief Technology Officer of iSono Health
Shadi loves solving challenging problems in healthcare that impact lives of so many, especially women. She believes consumer engagement in their own health through accessible and personalized medical technology is key to prevention and early detection. She has over 10 years of experience designing consumer electronic. Before co-founding iSonoHealth, she worked at broadcom and Intel. She has a Ph.D. in Electrical and Computer Engineering from Carnegie Mellon.
Follow Shadi Saberi:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Maryam Ziaei
Co-Founder & Chief Executive Officer of iSono Health
Maryam Ziaei is the Co-Founder & CEO at iSono Health.
Follow Maryam Ziaei:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Elad Walach
CEO and Co-Founder of Aidoc
Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad has led the company through 2 rounds of investment (total of $13Mil), driven the commercial availability of 2 product lines (detecting brain hemorrhages and C-Spine fractures), and created an install base of 16 global health systems while growing the company to over 50 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects. Elad holds a B.Sc. in Mathematics and Physics from The Hebrew University of Jerusalem, and has published multiple academic papers on deep learning.
Follow Elad Walach:
About Aidoc: Aidoc specializes in developing artificial intelligence tools for radiologists and multidisciplinary response teams.
Ren Menon
Co-Founder and CEO of OrthoFX
Ren Menon is currently serving as the managing director of Silicon Valley Capital where he is leading the firm’s diversification into the health and wellness sectors. Prior to Silicon Valley Capital, Mr. Menon held several leadership roles at Invisalign including head of global product development & innovation, head of North America commercial operations, Director – R & D and more. He played a critical role is helping grow Invisalign’s annual revenues to $900MM+ while attaining a market cap of $7B+. Mr. Menon was also the co-founder/CEO of Goldenslate – a big data analytics powered search engine to empower consumers to make informed, trust based choices when selecting critical care service providers. He exited his stake in Goldenslate through a planned sale. Over his 20 year career, he has held leadership roles in general management, product development, sales & marketing. Mr. Menon is currently a strategic advisor to Kairos society. He also sits on the board of SPCA and several privately held healthcare technology companies.
Follow Ren Menon:
About OrthoFX: Innovation Leader in Clear Aligner Orthodontics
Nichole Garcia
Co-Founder of OrthoFX
Nichole Garcia is a Co-Founder at OrthoFX.
Follow Nichole Garcia:
About OrthoFX: Innovation Leader in Clear Aligner Orthodontics
Henry Chan
Co-Founder & CTO of OrthoFX
Henry Chan is a Co-Founder and CTO at OrthoFX.
Follow Henry Chan:
About OrthoFX: Innovation Leader in Clear Aligner Orthodontics
Aaron Hsu
CEO and Co-Founder of ClearMask
Clinical researcher turned Social Entrepreneur that is Making Healthcare More Human. Love helping other entrepreneurs help make the world a better place. Let’s connect and see how we can work together!
Follow Aaron Hsu:
About ClearMask, Johns Hopkins University School of Medicine: ClearMask™ is a company manufatures the first full-face, transparent surgical mask.
Ritankar Das
Founder & Chief Executive Officer of Dascena
Ritankar Das is the founder and CEO of Dascena
Follow Ritankar Das:
About Dascena: Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Guangqiang Jiang
Co-Founder & Chief Technology Officer of Axonics Modulation Technologies
Dr. Jiang is a seasoned technical executive with a 15-year track record of developing complex, implantable Class III medical devices. He was previously VP of R&D at the Alfred Mann Foundation. Dr Jiang was elected to the American Institute for Medical and Biological Engineering (AIMBE)’s College of Fellows and served as Principal Investigator on several government contracts. Dr Jiang holds a Ph.D. in Biomedical Engineering from the University of Southern California.
Follow Guangqiang Jiang:
About Axonics Modulation Technologies: Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
